会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 5. 发明授权
    • Quinazoline derivatives
    • 喹唑啉衍生物
    • US4223143A
    • 1980-09-16
    • US968577
    • 1978-12-11
    • Eckehard K. T. CunyFrieder W. Lichtenthaler
    • Eckehard K. T. CunyFrieder W. Lichtenthaler
    • C07D231/56C07D239/88C07D487/04
    • C07D487/04C07D231/56C07D239/88
    • Novel quinazoline derivatives of the formula (1) ##STR1## wherein ring C is a pyrazole ring fused to ring B in two vicinal positions thereof that are not fused with ring A. The novel formula (1) compounds or pyrazolo-quinazoline-ones are structurally related to allopurinol, a well known drug useful in the treatment of gout and are expected to replace or complement allopurinol in the therapeutic use thereof. The generic name Benzoallopurinol is suggested for the novel formula (1) compounds; formula (1) includes angular and linear structures of the interfused rings A, B and C.Two methods for producing the novel formula (1) compounds are disclosed. The first method starts from the indazole structure that includes the interfused rings B and C, and ring A is formed on the indazole moiety. The second method starts from the quinazoline structure that includes interfused rings A and B, and the pyrazole ring C is formed on the benzo moiety (ring B) of the quinazoline structure. Either method may lead to angular or linear benzoallopurinols depending upon the substituents introduced into the starting structure for forming the complemental ring thereon.
    • 新的式(1)化合物或吡唑并喹唑啉衍生物(1)其中环C是与环B的两个相邻位置稠合的环B的吡唑环。 - 酮在结构上与别嘌呤醇有关,别嘌呤醇是用于治疗痛风的众所周知的药物,并且预期在其治疗用途中替代或补充别嘌呤醇。 对于新型配方(1)化合物,建议通用名称苯并嘌呤; 公式(1)包括界面环A,B和C的角度和线性结构。公开了制备新式(1)化合物的两种方法。 第一种方法是从包含界面环B和C的吲唑结构开始,在吲唑部分上形成环A。 第二种方法从包括嵌段环A和B的喹唑啉结构开始,吡唑环C形成在喹唑啉结构的苯并部分(环B)上。 根据引入到起始结构中的取代基来形成其上的互补环,任一方法都可能导致角或线性的苯并嘌呤醇。
    • 7. 发明授权
    • Cholesterol-lowering phenoxyalkanoic acid esters
    • US4153803A
    • 1979-05-08
    • US773144
    • 1977-03-01
    • Kurt ThieleQuazi AhmedRudolf AdrianUlrich Jahn
    • Kurt ThieleQuazi AhmedRudolf AdrianUlrich Jahn
    • A61K31/22C07C59/68C07C59/70C07C69/712C07C69/736C07D211/46C07D213/30C07D473/08C07C69/76
    • C07C321/00C07C59/68C07C59/70C07D211/46C07D473/08
    • Compounds possessing pharmaceutical activity as substances able to lower the level of fatty substances in the blood possess the following general formula: ##STR1## wherein R represents hydrogen, halogen, hydroxy or alkyl or alkoxy containing from 1 to 4 carbon atoms;A.sup.1 and A.sup.2 which can be the same or different are hydrogen or alkyl containing from 1 to 9 carbon atoms such that A.sup.1 and A.sup.2 contain together not more than 10 carbon atoms,Y is oxygen, in which case X is benzyl, benzyloxy or benzylthio or benzyl, benzyloxy or benzylthio substituted by R and Z is amine, azacyclohydrocarbyloxy cycloalkoxy containing from 3 to 6 ring carbon atoms or tertiary aminoalkoxy or pivaloyloxyalkoxy in which the alkoxy group contains from 1 to 3 carbon atoms, or X is hydrogen and Z is pivaloyloxyalkoxy in which the alkoxy group contains from 1 to 3 carbon atoms, orY is oxygen, X is benzyl, benzyloxy or benzylthio or benzyl, benzyloxy or benzylthio substituted by R and Z is alkoxy containing from 1 to 4 carbon atoms, hydroxy or O.sup.- M.sup.+, M being a metal cation of Main Groups I, II or III of the Periodic System of the Elements or an organic base cation or ammonium ion, A.sup.1 and A.sup.2 being the same and being as aforesaid or being different with one of A.sup.1 and A.sup.2 being hydrogen or both being hydrogen and X being a para substituent with respect to Y in the benzene ring in the same general formula,Y is oxygen, X is hydrogen and Z is amine, azacyclohydrocarbyloxy or pivaloyloxyalkoxy in which the alkoxy group contains from 1 to 3 carbon atoms,Or Y is sulphur, in which case X is hydrogen, benzyl, benzyloxy or benzylthio or benzyl, benzyloxy or benzylthio substituted by R and Z is amine, azacyclohydrocarbyloxy, alkoxy containing from 1 to 4 carbon atoms, hydroxy, O.sup.- M.sup.+ wherein M is a metal cation of Main Groups I, II or III of the Periodic System of The Elements or an organic base cation or ammonium ion, cycloalkoxy containing from 3 to 6 ring carbon atoms or tertiaryaminoalkoxy, pivaloyloxyalkoxy or pyridyl-C-alkoxy in which the alkoxy group contains from 1 to 3 carbon atoms, and pharmacologically acceptable acid addition and quaternary ammonium salts of compounds containing basic groups, and optical isomers of said compounds when A.sup.1 and A.sup.2 are different.
    • 10. 发明授权
    • Method for production of imidazolyl vinyl ethers
    • 咪唑基乙烯基醚的制备方法
    • US4554356A
    • 1985-11-19
    • US692324
    • 1985-01-16
    • Ludwig ZirngiblKurt Thiele
    • Ludwig ZirngiblKurt Thiele
    • C07D233/00B01J31/02C07B61/00C07D233/60C07D233/68C07D233/70C07D233/91C07D333/00C07D401/00C07D409/00C07D521/00
    • C07D231/12C07D249/08
    • A process for the manufacture of imidazolylvinyl ethers of the formula ##STR1## wherein Im represents the substituted or unsubstituted 1-H-imidazol-1-yl group and An, R and Y are defined hereinbelow by condensation of a corresponding ketone of the formulaAr--CO--CHR--Im (II)with the splitting-off of a Z group, with a condensable substance of the formulaZ--Y (III)in the aqueous solution of a strong inorganic base, preferably in concentrated aqueous soda lye. The reaction may also be carried out in the presence of a second liquid organic phase, preferably benzene or toluene, especially in the presence of a phase transfer catalyst in this case. Through careful crystallization of the product manufactured according to this method, it is possible to manufacture approximately pure E-isomers of the imidazolylvinyl ether of formula (I), without the requirement of chromatographic separation.
    • PCT No.PCT / EP82 / 00010 Sec。 371日期1982年5月24日 102(e)日期1982年5月24日PCT提交1982年1月21日PCT公布。 出版物WO82 / 02552 日本1982年8月5日。一种制备式(I)的咪唑基乙烯基醚的方法,其中Im表示取代或未取代的1-H-咪唑-1-基,An,R和Y定义如下 通过将式Ar-CO-CHR-Im(II)的相应的酮与Z基团的分离与式ZY(III)的可冷凝物质在强无机碱的水溶液中缩合, 优选在浓缩的苏打碱液中。 反应也可以在第二液体有机相存在下进行,优选苯或甲苯,特别是在这种情况下在相转移催化剂存在下。 通过根据该方法制造的产品的仔细结晶,可以制备式(I)的咪唑基乙烯基醚的近似纯的E-异构体,而不需要色谱分离。